...
首页> 外文期刊>Statistical methods in medical research >Extrapolation of efficacy and other data to support the development of new medicines for children: A systematic review of methods
【24h】

Extrapolation of efficacy and other data to support the development of new medicines for children: A systematic review of methods

机译:支持疗效和其他数据的推断,以支持儿童新药物的发展:对方法的系统审查

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: When developing new medicines for children, the potential to extrapolate from adult data to reduce the experimental burden in children is well recognised. However, significant assumptions about the similarity of adults and children are needed for extrapolations to be biologically plausible. We reviewed the literature to identify statistical methods that could be used to optimise extrapolations in paediatric drug development programmes. Methods: Web of Science was used to identify papers proposing methods relevant for using data from a ‘source population’ to support inferences for a ‘target population’. Four key areas of methods development were targeted: paediatric clinical trials, trials extrapolating efficacy across ethnic groups or geographic regions, the use of historical data in contemporary clinical trials and using short-term endpoints to support inferences about long-term outcomes. Results: Searches identified 626 papers of which 52 met our inclusion criteria. From these we identified 102 methods comprising 58 Bayesian and 44 frequentist approaches. Most Bayesian methods (n?=?54) sought to use existing data in the source population to create an informative prior distribution for a future clinical trial. Of these, 46 allowed the source data to be down-weighted to account for potential differences between populations. Bayesian and frequentist versions of methods were found for assessing whether key parameters of source and target populations are commensurate (n?=?34). Fourteen frequentist methods synthesised data from different populations using a joint model or a weighted test statistic. Conclusions: Several methods were identified as potentially applicable to paediatric drug development. Methods which can accommodate a heterogeneous target population and which allow data from a source population to be down-weighted are preferred. Methods assessing the commensurability of parameters may be used to determine whether it is appropriate to pool dat
机译:目的:在为儿童开发新药物时,公认,从成年数据外推外推出的潜力得到了公认的。然而,需要对成人和儿童相似性的显着假设是在生物学上可言论的外推。我们审查了文献,以确定可用于优化儿科药物开发计划中的外推的统计方法。方法:科学网用于识别提出与使用“源人口”数据相关的方法,以支持“目标人口”的推断。有针对性的方法开发的四个关键领域:儿科临床试验,试验跨越民族或地理区域的推断疗效,在当代临床试验中使用历史数据,并使用短期终点来支持长期结果的推断。结果:搜索确定了626篇论文,其中52篇符合我们的纳入标准。从这些我们确定了102种方法,包括58个贝叶斯和44个频繁的方法。大多数贝叶斯方法(n?=?54)寻求使用源人口中的现有数据,以创建未来临床试验的信息丰富的先前分配。其中,46允许源数据减速以解释群体之间的潜在差异。发现贝叶斯和频繁的方法的方法,用于评估源和目标群体的关键参数是否相称(n?=?34)。十四频率方法使用联合模型或加权测试统计来综合来自不同群体的数据。结论:鉴定了几种方法,潜在适用于儿科药物发育。可以容纳异构目标群体的方法,并且允许从源群中允许向下加权的数据是优选的。评估参数的可致畸性的方法可用于确定是否适合池DAT

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号